Datar Cancer Genetics Private Limited - Company Profile

It is a healthcare private limited company based in Nashik, Maharashtra, India, established in 1992.

1992 Nashik, Maharashtra, India Active

Last Updated: December 22, 2025

About Datar Cancer Genetics Private Limited

Datar Cancer Genetics Private Limited, a active private limited company, was established on 24 June 1992 in Nashik, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U01110MH1992PTC067409. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹125.80 Cr and a paid-up capital of ₹120.41 Cr.

Formerly known as Datar Agro Plantations Limited, Datar Cancer Genetics Limited. It upholds a compliant status. Its leadership includes Sneha Rajan Datar (Director), Swati Satish Deshpande (Director), Rajan Bhalchandra Datar (Director). Past directors included Dayanand Sunil Sahane, Kamlesh Narsinh Morarji, Rajan Bhalchandra Datar. It holds ₹18.14 Cr open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 15 July 2024, with the balance sheet filed on 31 March 2024. It is based at F-8, D-Road, Ambad,, Nashik, Maharashtra, 422010.

Company Details

CIN/LLPIN
U01110MH1992PTC067409
Registration Number
067409
Incorporation Date
24 June 1992
Authorized Capital
₹125.80 Cr
Paid-Up Capital
₹120.41 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 125.80 Cr as on 22-12-2025
Paid Up Capital ₹ 120.41 Cr as on 22-12-2025
Company Age 33 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 18.14 Cr as on 22-12-2025
Satisfied Charges ₹ 1.38 Cr as on 22-12-2025
Revenue Growth **** 17.76% (FY 2023)
Profit Growth **** 2173.38% (FY 2023)
Ebitda **** 129.91% (FY 2023)
Net Worth 31.79% (FY 2023)
Total Assets **** 9.67% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Datar Cancer Genetics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Datar Cancer Genetics Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sneha Rajan Datar	Director	01 Apr 2013	Current
Swati Satish Deshpande	Director	23 Oct 2020	Current
Rajan Bhalchandra Datar	Director	25 Mar 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Director	01 Jun 2013	Past
Pramod Abcsdd	Managing Director	26 Oct 2020	Past
Pramod Abcsdd	Company Secretary	04 Nov 2020	Past
Pramod Abcsdd	Director	26 Oct 2020	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Datar Cancer Genetics.

Datar Cancer Genetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.76% increase. The company also saw a substantial improvement in profitability, with a 2173.38% increase in profit. The company's net worth Soared by an impressive increase of 31.79%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

17.76%

*******

Revenue from Operations

*******

13.07%

*******

Total Assets

*******

9.67%

*******

Profit or Loss

*******

2173.38%

*******

Net Worth

*******

31.79%

*******

EBITDA

*******

129.91%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Datar Cancer Genetics?

In 2023, Datar Cancer Genetics had a promoter holding of 98.03% and a public holding of 1.97%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹181,375,000.00

Satisfied Charges

₹13,810,000.00

Charges Breakdown by Lending Institutions

Others : 18.14 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Oct 2025	Others	₹18.14 Cr	Open
16 Jan 2023	Hdfc Bank Limited	₹9.29 M	Satisfied
20 Dec 2022	Hdfc Bank Limited	₹4.53 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Datar Cancer Genetics?

Unlock and access historical data on people associated with Datar Cancer Genetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Datar Cancer Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Datar Cancer Genetics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Datar Cancer Genetics

Recent Activity within the Organization

Charges

The activity A charge with Others amounted to Rs. 18.14 Cr with Charge ID 101186462 was registered on 18 Oct 2025. was completed.
18 Oct 2025
Director Appointment

The activity Vibhuti Rahul Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 23 Aug 2025 & has been associated with this company since 5 months 25 days . was completed.
23 Aug 2025
Charges

Progress on A charge registered on 16 Jan 2023 via Charge ID 100674091 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024. was documented.
16 Jul 2024
Charges

A charge registered on 20 Dec 2022 via Charge ID 100665917 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024. was recorded as a recent event.
16 Jul 2024
Annual General Meeting

Datar Cancer Genetics Private Limited last Annual general meeting of members was held on 15 Jul 2024 as per latest MCA records. was recorded as a recent event.
15 Jul 2024
Balance Sheet

Datar Cancer Genetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
31 Mar 2024

Explore recent activity and updates - View Recent Activity